Evidence map›Paper›PMID 30142934›Full record

ArticleMolecules (Basel, Switzerland)2018

Exogenous Heat Shock Cognate Protein 70 Suppresses LPS-Induced Inflammation by Down-Regulating NF-κB through MAPK and MMP-2/-9 Pathways in Macrophages.

Erna Sulistyowati, Mei-Yueh Lee, Lin-Chi Wu, Jong-Hau Hsu, Zen-Kong Dai, Bin-Nan Wu, Ming-Chung Lin, Jwu-Lai Yeh

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Anti-Inflammatory Effects of Extracellular Vesicles fromInternational journal of molecular sciences · 2024
    Article
  4. Extracellular Vesicles fromMarine drugs · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Erna SulistyowatiGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. dr_erna@unisma.ac.id.
Mei-Yueh LeeDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. lovellelee@hotmail.com.ORCID 0000-0001-8950-064X
Lin-Chi WuDepartment of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. a2813228@yahoo.com.tw.
Jong-Hau HsuGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. jhh936@yahoo.com.tw.
Zen-Kong DaiGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. zenkong@kmu.edu.tw.
Bin-Nan WuGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. binnan@kmu.edu.tw.ORCID 0000-0001-6593-5120
Ming-Chung LinDepartment of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan 736, Taiwan. mygegon@gmail.com.
Jwu-Lai YehGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. jwulai@kmu.edu.tw.ORCID 0000-0001-7101-5865
Kaohsiung Medical University · TWChi Mei Medical Center · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heat shock cognate protein 70 (HSC70), a molecular chaperone, is constitutively expressed by mammalian cells to regulate various cellular functions. It is associated with many diseases and is a potential therapeutic target. Although HSC70 also possesses an anti-inflammatory action, the mechanism of this action remains unclear. This current study aimed to assess the anti-inflammatory effects of HSC70 in murine macrophages RAW 264.7 exposed to lipopolysaccharides (LPS) and to explain its pathways. Mouse macrophages (RAW 264.7) in 0.1 µg/mL LPS incubation were pretreated with recombinant HSC70 (rHSC70) and different assays (Griess assay, enzyme-linked immune assay/ELISA, electrophoretic mobility shift assay/EMSA, gelatin zymography, and Western blotting) were performed to determine whether rHSC70 blocks pro-inflammatory mediators. The findings showed that rHSC70 attenuated the nitric oxide (NO) generation, tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) expressions in LPS-stimulated RAW264.7 cells. In addition, rHSC70 preconditioning suppressed the activities and expressions of matrix metalloproteinase-2 (MMP-2) and MMP-9. Finally, rHSC70 diminished the nuclear translocation of nuclear factor-κB (NF-κB) and reduced the phosphorylation of extracellular-signal regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinases (MAPK), and phosphatidylinositol-3-kinase (PI3K/Akt). We demonstrate that rHSC70 preconditioning exerts its anti-inflammatory effects through NO production constriction; TNF-α, and IL-6 suppression following down-regulation of inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), and MMP-2/MMP-9. Accordingly, it ameliorated the signal transduction of MAPKs, Akt/IκBα, and NF-κB pathways. Therefore, extracellular HSC70 plays a critical role in the innate immunity modulation and mechanisms of endogenous protective stimulation.

Indexed as

AnimalsCyclooxygenase 2HSC70 Heat-Shock ProteinsInflammationInterleukin-6LipopolysaccharidesMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMitogen-Activated Protein KinasesNF-kappa BNitric Oxide Synthase Type IIRAW 264.7 CellsTumor Necrosis Factor-alphaCyclooxygenase 2HSC70 Heat-Shock ProteinsInterleukin-6LipopolysaccharidesMatrix Metalloproteinase 2Matrix Metalloproteinase 9Mitogen-Activated Protein KinasesNF-kappa BNitric Oxide Synthase Type IITumor Necrosis Factor-alphaheat shock proteininflammationlipopolysaccharidematrix metalloproteinasesRAW264.7 macrophages

Identifiers

PMID30142934
PMCPMC6225271
OpenAlexW2888066137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.